Comparing with Synthetic Nicotine , 22nd century group, Inc. (OTCBB: XXII) announced today that the company’s NBB gene has obtained the license notice issued by the State Intellectual Property Office of the people’s Republic of China and the patent issued by the Australian Intellectual Property Office. The gene can regulate nicotine synthesis in tobacco plants. The company has developed breakthrough technologies for tobacco harm reduction and some smoking cessation products.

The national patents of China and Australia come from the international patent application PCT / ib2006 / 001741, which contains the method of producing low nicotine tobacco plants and the method of producing tobacco products using such plants. NBB not only regulates nicotine levels, but also regulates the synthesis of other nicotine, such as neonicotine and pseudoequine.

NBB gene is encoded by a protein called “nicotine synthase”, which is involved in the last step of nicotine biosynthesis, which has puzzled scientists for decades. The protein can be down-regulated or up-regulated, resulting in different tobacco varieties with different nicotine levels. Dr. Takashi Hashimoto of Nara Advanced University of science and Technology (NAIST) is a world-famous plant molecular biologist and the inventor of NBB technology. 22nd century funded NAIST’s R & D from 2005 to 2009, and NAIST returned in 2010 with various relevant patents, including NBB technology. International patent application PCT / ib2006 / 004043 contains a method for producing tobacco plants and high nicotine products using NBB.

We specialize in manufacturing chemical Synthetic Nicotine ( CAS No.: 54-11-5 ) in China. we have the highest technology and stable quality control , our factory has sophisticated technology production route to produce the above products ,welcome to inquiry it .Please contact us by e-mail nicotine@haihengpharma.com for quotation requests. Please provide quantity, purity, and any other specific requirements.

Synthetic NicotineSynthetic Nicotine is used for E-Liquid
Comparing with Synthetic Nicotine , 22nd century group, Inc. (OTCBB: XXII) announced today that the company's NBB gene has obtained the license notice issued by the State Intellectual Property Office of the people's Republic of China and the patent issued by the Australian Intellectual Property Office. The gene can regulate...